Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Nomogram and Prostate cancer, with related work in Prostatectomy, Cancer research, Oncology. Notable publications include 'FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression', 'RETRACTED: LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR ‐124‐3p / DNMT3B axis', and 'Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis'.
Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma
The ADRENAL score: A comprehensive scoring system for standardized evaluation of adrenal tumor
LINC00467 Promotes Prostate Cancer Progression via M2 Macrophage Polarization and the miR-494-3p/STAT3 Axis
Transvesical Retzius-Sparing Versus Standard Robot-Assisted Radical Prostatectomy: A Retrospective Propensity Score-Adjusted Analysis
Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up
Nomograms Combining Ultrasonic Features With Clinical and Pathological Features for Estimation of Delphian Lymph Node Metastasis Risk in Papillary Thyroid Carcinoma
Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study
RETRACTED: <scp>LINC00240</scp> promotes gastric cancer cell proliferation, migration and <scp>EMT</scp> via the <scp>miR</scp>‐124‐3p / <scp>DNMT3B</scp> axis
FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis
A 5‐gene prognostic nomogram predicting survival probability of glioblastoma patients
ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female
Computer-aided diagnosis of malignant or benign thyroid nodes based on ultrasound images
An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial.